Mid-Day Market Update: Oracle Shares Decline On Weak Results; Horizon Pharma Jumps

Midway through trading Wednesday, the Dow traded down 0.06 percent to 16,325.76 while the NASDAQ declined 0.24 percent to 4,323.03. The S&P also fell, dropping 0.07 percent to 1,870.96. Leading and Lagging Sectors
Wednesday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Horizon Pharma HZNP and Senomyx SNMX. In trading on Wednesday, basic materials shares were relative laggards, down on the day by about 0.33 percent. Top decliners in the sector included Amyris AMRS, off 3.2 percent, and DRDGOLD DRD, down around 4.4 percent. Top Headline
FedEx FDX reported a 5% gain in its third-quarter profit. FedEx's quarterly profit surged to $378 million, or $1.23 per share, compared to a year-ago profit of $361 million or $1.13 per share. Its revenue climbed to $11.3 billion versus $11.0 billion. However, analysts were estimating earnings of $1.45 per share on revenue of $11.47 billion. FedEx projects current-quarter earnings of $2.25 to $2.50 per share, and full-year earnings of $6.55 to $6.80 per share. Equities Trading UP
Prothena Corporation plc PRTA shares shot up 21.91 percent to $45.30 after the company reported clinical data to be presented at International Symposium on Amyloidosis. Morgan Stanley raised the price target on the stock from $35.00 to $53.00. Shares of Horizon Pharma HZNP got a boost, shooting up 15.74 percent to $16.99 after the company announced its plans to acquire privately held Vidara Therapeutics International for around $660 million. KB Home KBH was also up, gaining 7.69 percent to $19.04 after the company swung to a profit in the fiscal first quarter. KB Home posted a quarterly profit of $10.6 million, or $0.12 per share, versus a year-ago loss of $12.5 million, or $0.16 per share. Equities Trading DOWN
Shares of Renren RENN were down 12.07 percent to $3.32 after the company reported Q4 results. Renren expected Q1 sales of $23.0 million to 25.0 million, versus analysts' estimates of $30.20 million. Orbitz Worldwide OWW shares tumbled 7.99 percent to $8.24 after Goldman Sachs downgraded the stock from Neutral to Sell. Oracle ORCL was down, falling 2.65 percent to $37.81 after the company reported weaker-than-expected fiscal third-quarter earnings. Oracle's quarterly profit surged to $2.57 billion, or $0.56 per share, versus a year-ago profit of $2.5 billion, or $0.52 per share. Its revenue jumped to $9.31 billion versus $8.96 billion. Its adjusted profit came in at $0.68 per share. Commodities
In commodity news, oil traded up 0.22 percent to $99.92, while gold traded down 1.50 percent to $1,338.60. Silver traded down 1.26 percent Wednesday to $20.60, while copper fell 2.15 percent to $2.89. Euro zone
European shares were mixed today. The Spanish Ibex Index rose 0.56 percent, while Italy's FTSE MIB Index fell 0.43 percent. Meanwhile, the German DAX jumped 0.35 percent and the French CAC 40 declined 0.01 percent while U.K. shares fell 0.36 percent. Economics
The MBA reported that its index of mortgage application activity declined 1.2% in the week ended March 14. The US current account deficit shrank to $81.1 billion in the fourth quarter, versus a revised $96.4 billion in the third quarter. Crude stockpiles climbed 5.9 million barrels for the week ended March 14, the US Energy Information Administration reported. However, analysts were expecting a gain of 2.6 million barrels. Gasoline supplies slipped 1.5 million barrels, while distillate stockpiles tumbled 3.1 million barrels. The Federal Open Market Committee will announce its policy decision at 2:00 p.m. ET, while the Fed Chairwoman Janet Yellen will hold press briefing at 2:30 p.m. ET.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceEurozoneFuturesForexGlobalEcon #sEconomicsIntraday UpdateMarketsMoversTech
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!